Abdallah Sassine Geara, MD
Associate Professor of Clinical Medicine (Renal-Electrolyte and Hypertension)
Clinical Director, Glomerular Diseases Program, University of Pennsylvania
Director, The OncoNephrology Program, The University of Pennsylvania
Department: Medicine
Contact information
Renal, Electrolyte and Hypertension Division
The Hospital of the University of Pennsylvania, 1 Founders Pavilion
3400 spruce street
Philadelphia, PA 19104
The Hospital of the University of Pennsylvania, 1 Founders Pavilion
3400 spruce street
Philadelphia, PA 19104
Office: 215-662-2638
Fax: 215-615-0349
Fax: 215-615-0349
Education:
MD (Doctor of Medicine)
Lebanese University, Faculty of Medical Sciences, Beirut, Lebanon, 2005.
Permanent linkMD (Doctor of Medicine)
Lebanese University, Faculty of Medical Sciences, Beirut, Lebanon, 2005.
Description of Clinical Expertise
Onconephrology (Renal diseases in Cancer Patients)Glomerular Disease
Renal Amyloidosis
Kidney Vasculitis
Lupus Nephritis
Proteinuria
Hematuria
kidney biopsy
Description of Research Expertise
Glomerular diseasesOnconephrology
kidney biopsy
Selected Publications
Gupta S, Kaunfer SA, Chen KL, Dias JA, Vijayan A, Rajasekaran A, Prosek J, Truong HL, Wood A, Bassil C, Renaghan AD, Shah CV, Zhang J, Glezerman I, Carlos C, Kelly K, Passero CJ, Drappatz J, Abudayyeh A, Shin D, Sperati CJ, Yelvington BJ, Kanduri SR, Neyra JA, Edmonston D, Shirali AC, Bansal A, Geara A, Mithani Z, Ziolkowski SL, Rashidi A, Jakubowski J, Pujari A, Bond DA, Dotson EK, Wall SA, Patton JT, Barreto JN, Hermann SM, Sheikh MS, Baz RC, Lee JH, Lucchesi N, Kolman M, Rasheed MA, Afzal A, Kang D, Mahesh A, Hsu R, Nicolaysen A, Tefera K, Schretlen C, Miller RM, Velez JCQ, Flannery AH, Aklilu AM, Anand S, Chandrasekhara S, Donley V, Patel A, Ni J, Krishnamurthy S, Ali R, Yilmam OA, Wells SL, Ortega JL, Green-Lingren OL, Leaf RK, Sise ME, Nayak L, LaCasce AS, Leung N, Leaf DE.: "Glucarpidase for Treatment of High-Dose Methotrexate Toxicity" Blood january 2025.Keith W Hamilton 1, Elvis Hua 2, Lauren Dutcher 1, Holly Fernandez Lynch 3, Paul Junker 4, Abigail G Doucette 5, Danielle Werner 6, Ethan Z Kannel 7, Thomas Civitello 7, Peter Gabriel 5, Vivek N Ahya 6 8, Dina A Jacobs 9, Alfred Garfall 10, Keith Pratz 10, Kathleen O Degnan 1, Emily A Blumberg 1, Donna Capozzi 11, Ethan Craig 12 13, Patricia Takach 14, Aimee S Payne 15, Abdallah Geara 16, Helen Koenig 1, Lawrence Holzman 16, Pablo Tebas 1: Implementation of an Approach to Equitable Allocation of SARS-CoV-2 Monoclonal Antibodies for Preexposure Prophylaxis: Experience From a Single Medical Center. Open Forum Infectious Disease july 2024.
Reza Zonozi, MD, Faten Aqeel, MD, Dustin Le, MD, Frank B. Cortazar, MD, Jugal Thaker, MD, Maria Jose Zabala Ramirez, MD, Sebastian Eduardo Sattui Cortes, MD, Rose Mary Attieh, MD, Madeline Chung, MD, David H. Bulbin, DO, Aisha Shaikh, MD, Karina Guaman, BA, Julia Ford, MD, Colin Diffie, MD, Ora Gewurz-Singer, MD, Gabriel Sauvage, BS, Anushya Jeyabalan, MD, Abdallah Geara, MD, Isabelle Ayoub, MD, Andrew Bomback, MD, Lara L. Khoury, MD, Jason C. George, DO, Kenar D. Jhaveri, MD, Vimal Kumar Derebail, MD, John L. Niles, MD, Duvuru Geetha, MD: "Real-world experience with avacopan in ANCA-associated vasculitis" Kidney International Reports March 2024.
Michelle N Rheault 1, Charles E Alpers 1, Jonathan Barratt 1, Stewart Bieler 1, Pietro Canetta 1, Dong-Wan Chae 1, Gaia Coppock 1, Ulysses Diva 1, Loreto Gesualdo 1, Hiddo J L Heerspink 1, Jula K Inrig 1, Gianna M Kirsztajn 1, Donald Kohan 1, Radko Komers 1, Laura A Kooienga 1, Kenneth Lieberman 1, Alex Mercer 1, Irene L Noronha 1, Vlado Perkovic 1, Jai Radhakrishnan 1, William Rote 1, Brad Rovin 1, Vladimir Tesar 1, Hernán Trimarchi 1, James Tumlin 1, Muh Geot Wong 1, Howard Trachtman 1; DUPRO Steering Committee and DUPLEX Investigators: "Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis" NEJM december 2023.
Rovin, B, et al,: "Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial" Lancet november 2023.
Hiddo J L Heerspink 1, Jai Radhakrishnan 2, Charles E Alpers 3, Jonathan Barratt 4, Stewart Bieler 5, Ulysses Diva 6, Jula Inrig 6, Radko Komers 6, Alex Mercer 7, Irene L Noronha 8, Michelle N Rheault 9, William Rote 6, Brad Rovin 10, Howard Trachtman 11, Hernán Trimarchi 12, Muh Geot Wong 13, Vlado Perkovic 14; PROTECT Investigators: "Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial" Lancet May 2023.
Vinay Srinivasan, Bader Kfoury, Sarah Ahmad, Jordana Cohen, and Abdallah S Geara: Long term outcomes of bevacizumab-associated kidney adverse effects. Journal of Onco-Nephrology october 2022.
Amudala NA, Boukhlal S, Sheridan B, Langford CA, Geara A, Merkel PA, Cornec D.: "Obinutuzumab as Treatment for ANCA-Associated Vasculitis" Rheumatology (Oxford). december 2021.
Srinivasan V, Geara AS, Han S, Hogan JJ, Coppock G.: "Need for symptom monitoring in IgA nephropathy patients post COVID-19 vaccination" Clin Nephrol december 2021.
Liann Abu Salman, Christos Kallis, Matthew Palmer, Jehan Bahrainwala, Abdallah S Geara: "New-Onset Proteinuria in a Patient With Schwannoma" American Journal Of Kidney Disease september 2021.